scholarly journals Long-term safety and efficacy of subcutaneous pasireotide in patients with Cushing’s disease: interim results from a long-term real-world evidence study

Pituitary ◽  
2019 ◽  
Vol 22 (5) ◽  
pp. 542-551 ◽  
Author(s):  
Luca Manetti ◽  
Timo Deutschbein ◽  
Jochen Schopohl ◽  
Kevin C. J. Yuen ◽  
Michael Roughton ◽  
...  
Keyword(s):  
Real World ◽  
Cushing’S Disease ◽  
Cushing's Disease ◽  
Safety And Efficacy ◽  
Real World Evidence

Interim results of a non-interventional, observational study evaluating the long-term safety and efficacy of pasireotide sc in Cushing's disease

2018 ◽  
Author(s):  
Carla Giordano ◽  
Jochen Schopohl ◽  
Kevin C J Yuen ◽  
Ulrike Kriemler-Krahn ◽  
Jiang Li ◽  
...  
Keyword(s):  
Observational Study ◽  
Cushing’S Disease ◽  
Cushing's Disease ◽  
Safety And Efficacy

scholarly journals MON-445 Long-Term Results of an Ongoing Non-Interventional, Real-World Observational Study of Pasireotide SC in Cushing's Disease

2019 ◽  
Vol 3 (Supplement_1) ◽  
Author(s):  
Kevin Yuen ◽  
Carla Giordano ◽  
Timo Deutschbein ◽  
Luca Manetti ◽  
Michael Roughton ◽  
...  
Keyword(s):  
Observational Study ◽  
Real World ◽  
Cushing’S Disease ◽  
Long Term Results ◽  
Cushing's Disease

scholarly journals Pasireotide therapy in a rare and unusual case of plurihormonal pituitary macroadenoma

2013 ◽  
Vol 2013 ◽  
Author(s):  
Rajesh Rajendran ◽  
Sarita Naik ◽  
Derek D Sandeman ◽  
Azraai B Nasruddin
Keyword(s):  
Glycaemic Control ◽  
Cushing’S Disease ◽  
Pituitary Adenomas ◽  
Unusual Case ◽  
Cushing's Disease ◽  
List Type ◽  
Pituitary Macroadenoma ◽  
Safety And Efficacy ◽  
Gh Excess

Summary We report the use of pasireotide in a rare and unusual case of pituitary macroadenoma co-secreting GH, prolactin and ACTH. A 62-year-old Caucasian man presented with impotence. Clinically, he appeared acromegalic and subsequent investigations confirmed GH excess and hyperprolactinaemia. Magnetic resonance imaging (MRI) of pituitary revealed a large pituitary macroadenoma. He underwent trans-sphenoidal surgery and histology confirmed an adenoma with immunohistochemistry positive for ACTH, GH and prolactin. Acromegaly was not cured following surgery and inadequately controlled despite subsequent octreotide therapy. He underwent further debulking pituitary surgery, following which IGF1 levels improved but still high. This time adenoma cells showed immunohistochemistry positivity for ACTH only, following which subsequent investigations confirmed intermittent hypercortisolaemia compatible with pituitary Cushing's disease. We recommended radiotherapy, but in view of the pluripotential nature of the tumour, we proceeded with a trial of s.c. pasireotide therapy on the basis that it may control both his acromegaly and Cushing's disease. After 3 months of pasireotide therapy, his mean GH and IGF1 levels improved significantly, with improvement in his symptoms but intermittent hypercortisolaemia persists. His glycaemic control deteriorated requiring addition of new anti-diabetic medication. MRI imaging showed loss of contrast uptake within the tumour following pasireotide therapy but no change in size. We conclude that our patient has had a partial response to pasireotide therapy. Long-term follow-up studies are needed to establish its safety and efficacy in patients with acromegaly and/or Cushing's disease. Learning points Plurihormonal pituitary adenomas are rare and unusual. Patients with pituitary adenomas co-secreting ACTH and GH are more likely to present with acromegaly because GH excess can mask hypercortisolaemia. Pasireotide holds potential where conventional somatostatin analogues are not effective in acromegaly due to higher affinity for somatostatin receptor subtypes 1, 2, 3 and 5. Significant deterioration in glycaemic control remains a concern in the use of pasireotide. Currently, long-term safety and efficacy of pasireotide in patients with acromegaly and/or Cushing's disease are not fully clear.

scholarly journals The medical treatment with pasireotide in Cushing’s disease: an Italian multicentre experience based on “real-world evidence”

Endocrine ◽  
2019 ◽  
Vol 64 (3) ◽  
pp. 657-672 ◽  
Author(s):  
Rosario Pivonello ◽  
Giorgio Arnaldi ◽  
Carla Scaroni ◽  
Carla Giordano ◽  
Salvo Cannavò ◽  
...  
Keyword(s):  
Medical Treatment ◽  
Real World ◽  
Cushing’S Disease ◽  
Cushing's Disease ◽  
Real World Evidence

Endocrinological long-term follow-up study of patients bilaterally adrenalectomized for Cushing's disease

1987 ◽  
Vol 116 (3_Suppl) ◽  
pp. S107-S108
Author(s):  
A. EDELMANN ◽  
L. RADBRUCH ◽  
L. NOCKE-FINCK
Keyword(s):  
Cushing’S Disease ◽  
Cushing's Disease ◽  
Follow Up Study ◽  
Long Term Follow Up

Favorable long-term outcome of bilateral adrenalectomy in Cushing's disease

2014 ◽  
Author(s):  
Andrea Osswald ◽  
Eva Plomer ◽  
Christina Dimopoulou ◽  
Monika Milian ◽  
Rainer Blaser ◽  
...  
Keyword(s):  
Cushing’S Disease ◽  
Bilateral Adrenalectomy ◽  
Cushing's Disease ◽  
Term Outcome ◽  
Long Term Outcome

Long-term remission and recurrence rates after transsphenoidal surgery for cushing's disease

2014 ◽  
Author(s):  
Paloma Moreno Moreno ◽  
Julia Silva Fernandez ◽  
Maria Rosa Alhambra Exposito ◽  
Maria angeles Galvez Moreno
Keyword(s):  
Cushing’S Disease ◽  
Transsphenoidal Surgery ◽  
Cushing's Disease ◽  
Recurrence Rates
Sign in / Sign up

Export Citation Format

Share Document